FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Noble

Research Profile

Anatomy

Physiology

Living Beings

Rats
Mouse

Chemicals & Drugs

Concepts & Ideas

Procedures

Stem Cell Transplantation

Co-author Network

Publications

TOP 3
Mark Noble; Margot Mayer-Pröschel; Chris Pröschel
iOPs: A New Tool for Studying Myelin Pathologies?
Hsing-Yu Chen; Brett M Stevens; Yin M Yang; Mark Noble
Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.
Mark Noble; Chris Pröschel; Jeannette E Davies; Margot Mayer-Pröschel; Stephen J A Davies
Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Noble (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mark Noble; Margot Mayer-Pröschel; Chris Pröschel
iOPs: A New Tool for Studying Myelin Pathologies?
Cell stem cell 2013;12(5):503-4.
2013: Hsing-Yu Chen; Brett M Stevens; Yin M Yang; Mark Noble
Inhibition of redox/Fyn/c-Cbl pathway function by Cdc42 controls tumour initiation capacity and tamoxifen sensitivity in basal-like breast cancer cells.
EMBO molecular medicine 2013;5(5):723-36.
2011: Mark Noble; Chris Pröschel; Jeannette E Davies; Margot Mayer-Pröschel; Stephen J A Davies
Precursor cell biology and the development of astrocyte transplantation therapies: lessons from spinal cord injury.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2011;8(4):677-93.
2011: Mark Noble; Chris Pröschel; Margot Mayer-Pröschel
Oxidative-reductionist approaches to stem and progenitor cell function.
Cell stem cell 2011;8(1):1-2.
2011: Stephen J A Davies; Chung-Hsuan Shih; Mark Noble; Margot Mayer-Proschel; Jeannette E Davies; Christoph Proschel
Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury.
PloS one 2011;6(3):e17328.
2011: Rui Chen; Ollivier Hyrien; Mark Noble; Margot Mayer-Pröschel
A composite likelihood approach to the analysis of longitudinal clonal data on multitype cellular systems under an age-dependent branching process.
Biostatistics (Oxford, England) 2011;12(1):173-91.
2010: Ollivier Hyrien; Jörg Dietrich; Mark Noble
Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors.
Cancer research 2010;70(24):10051-9.
2010: Ollivier Hyrien; R Chen; Margot Mayer-Pröschel; Mark Noble
Saddlepoint approximations to the moments of multitype age-dependent branching processes, with applications.
Biometrics 2010;66(2):567-77.
2008: Ruolan Han; Yin M Yang; Jorg Dietrich; Anne Luebke; Margot Mayer-Pröschel; Mark Noble
Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system.
Journal of biology 2008;7(4):12.
2007: Zaibo Li; Tiefei Dong; Chris Pröschel; Mark Noble
Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function.
PLoS biology 2007;5(2):e35.
2006: Craig T Jordan; Monica L Guzman; Mark Noble
Cancer stem cells.
The New England journal of medicine 2006;355(12):1253-61.
2006: Mark Noble
Implications for CNS repair of redox modulation of cell survival, division and differentiation.
Current Alzheimer research 2006;3(1):37-47.
2006: Jorg Dietrich; Ruolan Han; Yin Yang; Margot Mayer-Pröschel; Mark Noble
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.
Journal of biology 2006;5(7):22.
2006: Ollivier Hyrien; Ibro Ambeskovic; Margot Mayer-Proschel; Mark Noble; Andrei Yakovlev
Stochastic modeling of oligodendrocyte generation in cell culture: model validation with time-lapse data.
Theoretical biology & medical modelling 2006;3():21.
2006: Jeannette E Davies; Carol Huang; Christoph Proschel; Mark Noble; Margot Mayer-Proschel; Stephen J A Davies
Astrocytes derived from glial-restricted precursors promote spinal cord repair.
Journal of biology 2006;5(3):7.
2005: Mark Noble
Ethics in the trenches: a multifaceted analysis of the stem cell debate.
Stem cell reviews 2005;1(4):345-76.
2005: Mark Noble; Margot Mayer-Pröschel; Chris Pröschel
Redox regulation of precursor cell function: insights and paradoxes.
Antioxidants & redox signaling 2005;7(11-12):1456-67.
2005: Ollivier Hyrien; Margot Mayer-Pröschel; Mark Noble; Andrei Yakovlev
A stochastic model to analyze clonal data on multi-type cell populations.
Biometrics 2005;61(1):199-207.
2005: Jorg Dietrich; Michelle Lacagnina; David Adam Gass; Eric Richfield; Margot Mayer-Pröschel; Mark Noble; Carlos Torres; Chris Pröschel
EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
Nature medicine 2005;11(3):277-83.
2005: Ollivier Hyrien; Margot Mayer-Pröschel; Mark Noble; Andrei Yakovlev
Estimating the life-span of oligodendrocytes from clonal data on their development in cell culture.
Mathematical biosciences 2005;193(2):255-74.
2004: Caitlin E Hill; Christoph Proschel; Mark Noble; Margot Mayer-Proschel; John C Gensel; Michael S Beattie; Jacqueline C Bresnahan
Acute transplantation of glial-restricted precursor cells into spinal cord contusion injuries: survival, differentiation, and effects on lesion environment and axonal regeneration.
Experimental neurology 2004;190(2):289-310.
2004: Mark Noble; Jorg Dietrich
The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity.
Trends in neurosciences 2004;27(3):148-54.
2004: Mark Noble; Chris Pröschel; Margot Mayer-Pröschel
Getting a GR(i)P on oligodendrocyte development.
Developmental biology 2004;265(1):33-52.
2004: Mark Noble
The possible role of myelin destruction as a precipitating event in Alzheimer's disease.
Neurobiology of aging 2004;25(1):25-31.
2003: Mark Noble; Joel Smith; Jennifer Power; Margot Mayer-Pröschel
Redox state as a central modulator of precursor cell function.
Annals of the New York Academy of Sciences 2003;991():251-71.
2003: Mark Noble; A Arhin; David Adam Gass; Margot Mayer-Pröschel
The cortical ancestry of oligodendrocytes: common principles and novel features.
Developmental neuroscience 2003;25(2-4):217-33.
2002: Jorg Dietrich; Mark Noble; Margot Mayer-Proschel
Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells.
Glia 2002;40(1):65-77.
2002: Jennifer Power; Margot Mayer-Pröschel; Joel Smith; Mark Noble
Oligodendrocyte precursor cells from different brain regions express divergent properties consistent with the differing time courses of myelination in these regions.
Developmental biology 2002;245(2):362-75.
2002: Mark Noble; Jorg Dietrich
Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage.
Trends in neurosciences 2002;25(2):103-7.
2002: Ninel Z Gregori; Chris Pröschel; Mark Noble; Margot Mayer-Pröschel
The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2002;22(1):248-56.
2001: Kenneth M Boucher; AV Zorin; Andrei Y Yakovlev; Margot Mayer-Proschel; Mark Noble
An alternative stochastic model of generation of oligodendrocytes in cell culture.
Journal of mathematical biology 2001;43(1):22-36.
2001: Margot Mayer-Pröschel; Daniel J Morath; Mark Noble
Are hypothyroidism and iron deficiency precursor cell diseases?
Developmental neuroscience 2001;23(4-5):277-86.
2000: Mark Noble
Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a means of repairing tumor-associated damage?
Proceedings of the National Academy of Sciences of the United States of America 2000;97(23):12393-5.
2000: AV Zorin; Margot Mayer-Proschel; Mark Noble; Andrei Y Yakovlev
Estimation problems associated with stochastic modeling of proliferation and differentiation of O-2A progenitor cells in vitro.
Mathematical biosciences 2000;167(2):109-21.
2000: J Smith; E Ladi; Margot Mayer-Proschel; Mark Noble
Redox state is a central modulator of the balance between self-renewal and differentiation in a dividing glial precursor cell.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(18):10032-7.
2000: Mark Noble
Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors?
Nature medicine 2000;6(4):369-70.
2000: Mark Noble
Precursor cell transitions in oligodendrocyte development.
The Journal of cell biology 2000;148(5):839-42.
1999: E von Collani; Alexander Tsodikov; Andrei Yakovlev; Margot Mayer-Proschel; Mark Noble
A random walk model of oligodendrocyte generation in vitro and associated estimation problems.
Mathematical biosciences 1999;159(2):189-204.
1999: Kenneth M Boucher; Andrei Y Yakovlev; Margot Mayer-Proschel; Mark Noble
A stochastic model of temporally regulated generation of oligodendrocytes in cell culture.
Mathematical biosciences 1999;159(1):47-78.
1999: Mark Noble
Production and growth of conditionally immortal cell lines from the H-2KbtsA58 transgenic mouse.
Methods in molecular biology (Clifton, N.J.) 1999;97():139-58.
1998: Andrei Y Yakovlev; Kenneth M Boucher; Margot Mayer-Proschel; Mark Noble
Quantitative insight into proliferation and differentiation of oligodendrocyte type 2 astrocyte progenitor cells in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(24):14164-7.
1998: Andrei Y Yakovlev; Margot Mayer-Proschel; Mark Noble
A stochastic model of brain cell differentiation in tissue culture.
Journal of mathematical biology 1998;37(1):49-60.
1998: Mahendra S Rao; Mark Noble; Margot Mayer-Pröschel
A tripotential glial precursor cell is present in the developing spinal cord.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(7):3996-4001.
1997: Mark Noble; Margot Mayer-Pröschel
Growth factors, glia and gliomas.
Journal of neuro-oncology 1997;35(3):193-209.
1997: C L Florian; T Pietsch; Mark Noble; Stephen R Williams
Metabolic studies of human primitive neuroectodermal tumour cells by proton nuclear magnetic resonance spectroscopy.
British journal of cancer 1997;75(7):1007-13.
1996: N Ibarrola; Margot Mayer-Pröschel; A Rodriguez-Peña; Mark Noble
Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro.
Developmental biology 1996;180(1):1-21.
1996: J M Frangiskakis; A K Ewart; CA Morris; Carolyn Beth Mervis; J Bertrand; Byron Robinson; B P Klein; Gregory J Ensing; L A Everett; Eric Green; C Pröschel; N J Gutowski; Mark Noble; Donald L Atkinson; S J Odelberg; Mark T Keating
LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition.
Cell 1996;86(1):59-69.
1996: X Mao; T A Jones; J Williamson; N J Gutowski; C Pröschel; Mark Noble; Denise Sheer
Assignment of the human and mouse LIM-kinase genes (LIMK1; Limk1) to chromosome bands 7q11.23 and 5G1, respectively, by in situ hybridization.
Cytogenetics and cell genetics 1996;74(3):190-1.
1996: Mark Noble; M Mayer-Próschel
On the track of cell survival pharmaceuticals in the oligodendrocyte type-2 astrocyte lineage.
Perspectives on developmental neurobiology 1996;3(2):121-31.
1995: Mark Noble; N Gutowski; K Bevan; U Engel; M Linskey; J Urenjak; K Bhakoo; S Williams
From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage.
Glia 1995;15(3):222-30.
1995: C Pröschel; M J Blouin; N J Gutowski; R Ludwig; Mark Noble
Limk1 is predominantly expressed in neural tissues and phosphorylates serine, threonine and tyrosine residues in vitro.
Oncogene 1995;11(7):1271-81.
1995: C L Florian; N E Preece; K K Bhakoo; Stephen R Williams; Mark Noble
Characteristic metabolic profiles revealed by 1H NMR spectroscopy for three types of human brain and nervous system tumours.
NMR in biomedicine 1995;8(6):253-64.
1995: Mark Noble; Andrew Groves; P Ataliotis; Z Ikram; Parmjit S Jat
The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines.
Transgenic research 1995;4(4):215-25.
1994: M Mayer; Mark Noble
N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(16):7496-500.
1994: Oliver Bogler; Mark Noble
Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division.
Developmental biology 1994;162(2):525-38.
1994: M Mayer; K Bhakoo; Mark Noble
Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro.
Development (Cambridge, England) 1994;120(1):143-53.
1994: Mark Noble
The O-2A lineage: from rats to humans.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1994;135():67-75.
1993: Oliver Bogler; A Entwistle; Rainer Kuhn; E Monuki; G Lemke; Mark Noble
Single cell analysis of the expression of a nuclear protein, SCIP, by fluorescent immunohistochemistry visualized with confocal microscopy.
The Histochemical journal 1993;25(10):746-61.
1993: Andrew Groves; A Entwistle; Parmjit S Jat; Mark Noble
The characterization of astrocyte cell lines that display properties of glial scar tissue.
Developmental biology 1993;159(1):87-104.
1993: M Mayer; O Bögler; Mark Noble
The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overridden by astrocytes.
Glia 1993;8(1):12-9.
1993: Andrew Groves; Susan C Barnett; Robin J M Franklin; A John Crang; M Mayer; William F Blakemore; Mark Noble
Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells.
Nature 1993;362(6419):453-5.
1993: Susan C Barnett; A M Hutchins; Mark Noble
Purification of olfactory nerve ensheathing cells from the olfactory bulb.
Developmental biology 1993;155(2):337-50.
1992: Mark Noble; D Wren; G Wolswijk
The O-2A(adult) progenitor cell: a glial stem cell of the adult central nervous system.
Seminars in cell biology 1992;3(6):413-22.
1992: Mark Noble; G Wolswijk
Development and regeneration in the O-2A lineage: studies in vitro and in vivo.
Journal of neuroimmunology 1992;40(2-3):287-93.
1992: A John Crang; Robin J M Franklin; William F Blakemore; Mark Noble; Susan C Barnett; Andrew Groves; Jacqueline Trotter; M Schachner
The differentiation of glial cell progenitor populations following transplantation into non-repairing central nervous system glial lesions in adult animals.
Journal of neuroimmunology 1992;40(2-3):243-53.
1992: G Wolswijk; Mark Noble
Cooperation between PDGF and FGF converts slowly dividing O-2Aadult progenitor cells to rapidly dividing cells with characteristics of O-2Aperinatal progenitor cells.
The Journal of cell biology 1992;118(4):889-900.
1992: A Entwistle; Mark Noble
The quantification of fluorescent emission from biological samples using analysis of polarization.
Journal of microscopy 1992;165(Pt 3):347-65.
1992: D Wren; G Wolswijk; Mark Noble
In vitro analysis of the origin and maintenance of O-2Aadult progenitor cells.
The Journal of cell biology 1992;116(1):167-76.
1992: Mark Noble; Andrew Groves; P Ataliotis; Parmjit S Jat
From chance to choice in the generation of neural cell lines.
Brain pathology (Zurich, Switzerland) 1992;2(1):39-46.
1992: Mark Noble; O D Wiestler
Gene transfer into the nervous system.
Brain pathology (Zurich, Switzerland) 1992;2(1):21-2.
1991: Alastair Compston; Neil Scolding; D Wren; Mark Noble
The pathogenesis of demyelinating disease: insights from cell biology.
Trends in neurosciences 1991;14(5):175-82.
1991: Andrew Groves; O Bögler; Parmjit S Jat; Mark Noble
The cellular measurement of time.
Current opinion in cell biology 1991;3(2):224-9.
1991: G Wolswijk; P N Riddle; Mark Noble
Platelet-derived growth factor is mitogenic for O-2Aadult progenitor cells.
Glia 1991;4(5):495-503.
1991: Mark Noble
Points of controversy in the O-2A lineage: clocks and type-2 astrocytes.
Glia 1991;4(2):157-64.
1991: A John Crang; Robin J M Franklin; William F Blakemore; Jacqueline Trotter; M Schachner; Susan C Barnett; Mark Noble
Transplantation of normal and genetically engineered glia into areas of demyelination.
Annals of the New York Academy of Sciences 1991;633():563-5.
1991: O Bögler; Mark Noble
Studies relating differentiation to a mechanism that measures time in O-2A progenitor cells.
Annals of the New York Academy of Sciences 1991;633():505-7.
1991: G Wolswijk; P M Munro; P N Riddle; Mark Noble
Origin, growth factor responses, and ultrastructural characteristics of an adult-specific glial progenitor cell.
Annals of the New York Academy of Sciences 1991;633():502-4.
1991: Mark Noble; P Ataliotis; Susan C Barnett; K Bevan; O Bögler; Andrew Groves; Parmjit S Jat; G Wolswijk; D Wren
Development, regeneration, and neoplasia of glial cells in the central nervous system.
Annals of the New York Academy of Sciences 1991;633():35-47.
1990: O Bögler; D Wren; Susan C Barnett; H Land; Mark Noble
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(16):6368-72.
1990: G Wolswijk; P N Riddle; Mark Noble
Coexistence of perinatal and adult forms of a glial progenitor cell during development of the rat optic nerve.
Development (Cambridge, England) 1990;109(3):691-8.
1990: Mark Noble; J Fok-Seang; G Wolswijk; D Wren
Development and regeneration in the central nervous system.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1990;327(1239):127-43.
1990: Mark Noble; Susan C Barnett; O Bögler; H Land; G Wolswijk; D Wren
Control of division and differentiation in oligodendrocyte-type-2 astrocyte progenitor cells.
Ciba Foundation symposium 1990;150():227-43; discussion 244-9.
1989: D R Wren; Mark Noble
Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(22):9025-9.
1989: G Wolswijk; Mark Noble
Identification of an adult-specific glial progenitor cell.
Development (Cambridge, England) 1989;105(2):387-400.
1989: Mark Noble; G Wolswijk; D Wren
The complex relationship between cell division and the control of differentiation in oligodendrocyte-type-2 astrocyte progenitor cells isolated from perinatal and adult rat optic nerves.
Progress in growth factor research 1989;1(3):179-94.
1988: V L Calder; G Wolswijk; Mark Noble
The differentiation of O-2A progenitor cells into oligodendrocytes is associated with a loss of inducibility of Ia antigens.
European journal of immunology 1988;18(8):1195-201.
1988: Mark Noble; K Murray; P Stroobant; Michael D Waterfield; P Riddle
Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell.
Nature 1988;333(6173):560-2.